Massive study settles decades-old breast cancer treatment debate

A landmark analysis of 100,000 women across 86 trials confirms that two leading chemotherapy approaches work equally well for early-stage breast cancer. The finding could reshape treatment protocols globally and help oncologists tailor care to individual patients rather than relying on one-size-fits-all regimens.

Originaltitel: Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials